COVAX and the African Union declined to exercise options to purchase additional doses of Moderna vaccine from COVID-19. Deliveries included 166 million doses in Q3 and 166 million doses in Q4 of this year. The refusal is associated with difficulties in distribution in developing countries of already delivered 300 million doses of the vaccine.